Effects of dual antiplatelet therapy on cerebral microbleeds in patients with coronary artery disease

Effects of dual antiplatelet therapy on cerebral microbleeds in patients with coronary artery disease - Effects of DAPT on cerebral microbleeds in CAD patients

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000007367

Enrollment

100

Registered

2012-02-27

Start date

2012-03-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Coronary artery disease

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Angiographically proven CAD patients who undergo DAPT (e.g. patients undergoing drug-eluting stent implantation)(DAPT group) and age-, gender-, and coronary lesion severity-matched patients undergoing aspirin monotherapy (SAPT group)

Exclusion criteria

Exclusion criteria: Acute coronary syndrome Contraindication for MRI Contraindication for aspirin and/or clopidogrel

Design outcomes

Primary

Measure	Time frame
Localization and number of new CMBs after 8-month treatment	—

Secondary

Measure	Time frame
Location and number of new lesions of cerebral infarction and cerebral bleeding White matter hyperintensity Carotid/intracranial arterial lesions	—

Countries

Japan

Contacts

Public ContactYoshiko Iwamoto

Kurume University School of Medicine Cardio-vascular Medicine

iwamoto_yoshiko@med.kurume-u.ac.jp+81-942-31-7562

Outcome results